ClinicalTrials.gg
RecruitingNCT06620471Updated May 20, 2026

Assessing the Enhanced Precision: The Value of Impedance in Ultrasound-Guided Nerve Blocks (Axillary, Interscalene, Popliteal Sciatic), an Exploratory Prospective Observational Study

An observational study in Impedance, Axillary Nerve Block and Ultrasound-Guided Nerve Blocks, sponsored by Lebanese American University. Recruiting at 1 site in Lebanon. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-05-20.

Sponsored by Lebanese American University · Observational

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 5 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years to 90 Years
Sex
All
01

Study summary

Impedance can have an impact on nerve block during loco-regional anesthesia, particularly when using techniques such as nerve stimulation or ultrasound guidance to locate and block specific nerves. Impedance refers to the resistance to electrical current flow within tissue, and it can affect the ability to stimulate nerves or visualize them using ultrasound. The aim of this research is to assess the impedance across different tissue type during an axillary peripheral nerve block (skin, fat, fascia, muscle, nerve proximity). The results of this study would help clinicians performing nerve block to enhance the precision of needle placement, thus increase the success rate of nerve block and reduce adverse events such as intraneural or intravascular injections.

02

Conditions studied

  • Impedance
  • Axillary Nerve Block
  • Ultrasound-Guided Nerve Blocks
  • Interscalene Nerve Block
  • Popliteal Sciatic Nerve Block
03

In context

Lead sponsor

Lebanese American University is the lead sponsor of 16 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Community sample

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Individuals aged 18 years to 90 years old
  • No infection at the injection site
  • Patient signed the study consent form
  • No for nerve block
  • No allergies to any of the drugs used
  • Patient able to communicate effectively

Exclusion criteria

Exclusion Criteria:

  • Patients not meeting the inclusion criteria
  • Patients with bleeding disorders or undergoing anticoagulation therapy
  • Pregnant patients
  • Patients with mental incapacity
  • Any medical conditions posing severe risks during the procedure
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (estimated)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Assess the impedance across different type of tissue during axillary, popliteal and interscalene nerve block

    Measure impedance at different locations, different tissue types and different distances from the nerve (as recorded on the nerve stimulator)

    Time frame: Two years

07

Study locations

1 of 1 sites recruiting
  • Lebanese American University Rizk Hospital
    Beirut, Beirut, Lebanon
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jun 2024 (actual). Primary completion is estimated for Nov 2026, 29 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2024
First posted
Oct 1, 2024
StartActual
Jun 10, 2024
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
May 20, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06620471
Lead sponsor
Lebanese American University
Responsible party
Georges Assaf (M.D. Anesthesiologist, Lebanese American University) — Principal investigator
First posted
Oct 1, 2024
Start date
Jun 10, 2024
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
May 20, 2026

Study contacts

Assaf, M.D. anesthesiology
Contact
georges.assaf@laumcrh.com
+961 3 970 762
Michel Youssef Akiki, M.D. anesthesiology resident
Contact
michel.akiki@lau.edu
+ 961 71159586

Oversight

Data monitoring committee
No
FDA-regulated drug
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion